Sunday, March 7, 2021  | 22 Rajab, 1442
Samaa TV
Facebook Twitter Youtube
HOME > Health

Pakistan decides to import Sinopharm COVID-19 vaccine: Fawad Chaudhry

1.2 million doses will be purchased initially

SAMAA | - Posted: Dec 31, 2020 | Last Updated: 2 months ago
SAMAA |
Posted: Dec 31, 2020 | Last Updated: 2 months ago
Pakistan decides to import Sinopharm COVID-19 vaccine: Fawad Chaudhry

Photo: AFP

Listen
Federal Minister for Science and Technology Fawad Chaudhry said on Thursday that the cabinet committee has decided to buy the COVID-19 vaccine from Chinese company Sinopharm. "Initially, 1.2 million doses will be purchased from Sinopharm," the federal science minister said on Twitter. The vaccine will be given free of charge to frontline workers in the first quarter of 2021. He added that the private sector could also import vaccines that had been approved for use across the world. On Wednesday, Federal Planning Minister and NCOC Chief Asad Umar tweeted: "Authorized procurement of more than 1 million vaccines which will cover all frontline health workers, as soon as DRAP expert committee approves vaccine." Held meeting of cabinet committee for procurement of vaccines. Authorized procurement of more than 1 million vaccines which will cover all frontline health workers, as soon as DRAP expert committee approves vaccine. Target is to deploy these vaccines within 1st quarter of 2021.— Asad Umar (@Asad_Umar) December 30, 2020 China approved on Thursday its locally-manufactured Sinopharm vaccine after results of its clinical trials were released. The firm had announced that the vaccine had an efficacy rate of 79% based on early analysis of Phase 3 trials. The vaccine has already been rolled out in the UAE and Bahrain. The UAE began emergency use on September 14 and approved the vaccine for full use on December 6. Bahrain began inoculating health workers on December 13.
FaceBook WhatsApp

Federal Minister for Science and Technology Fawad Chaudhry said on Thursday that the cabinet committee has decided to buy the COVID-19 vaccine from Chinese company Sinopharm.

“Initially, 1.2 million doses will be purchased from Sinopharm,” the federal science minister said on Twitter.

The vaccine will be given free of charge to frontline workers in the first quarter of 2021. He added that the private sector could also import vaccines that had been approved for use across the world.

On Wednesday, Federal Planning Minister and NCOC Chief Asad Umar tweeted: “Authorized procurement of more than 1 million vaccines which will cover all frontline health workers, as soon as DRAP expert committee approves vaccine.”

China approved on Thursday its locally-manufactured Sinopharm vaccine after results of its clinical trials were released. The firm had announced that the vaccine had an efficacy rate of 79% based on early analysis of Phase 3 trials.

The vaccine has already been rolled out in the UAE and Bahrain. The UAE began emergency use on September 14 and approved the vaccine for full use on December 6. Bahrain began inoculating health workers on December 13.

 
HOME  
 
 
RELATED STORIES

One Comment

  1. Syed Hasan Aftab  December 31, 2020 4:48 pm/ Reply

    start innoculations rapidly to avoid further lockdowns and economic disasters.
    China is our most trusted friend and will likely give Pakistan this vaccine at a discounted rate.
    Everyone must get vaccinated quickly so normal life can begin

Tell us what you think:

Your email address will not be published.

 
 
 
 

MOST READ
MOST READ
COVID-19 vaccine updates in Pakistan and around the world
Karachi water supply to be disrupted for 72 hours: KWSB
Three PTI MPAs have gone missing in Karachi: Khurram Zaman
PM Imran Khan wins National Assembly’s confidence
Islamabad murder: Protesters block Murree Road
Pakistani drug lords take Nigerian mafia for a ride
Indian airplane makes emergency landing in Karachi
 
 
 
 
 
About Us   |   Anchor Profiles   |   Online Advertising   |   Contact Us   |   Feedback   |   Apps   |   FAQs   |   Authors   |   Comment Policy
Facebook   |   Twitter   |   Instagram   |   YouTube   |   WhatsApp